Skip to main content
Top
Published in: Breast Cancer 1/2015

01-01-2015 | Review Article

Focal breast edema associated with malignancy on T2-weighted images of breast MRI: peritumoral edema, prepectoral edema, and subcutaneous edema

Author: Takayoshi Uematsu

Published in: Breast Cancer | Issue 1/2015

Login to get access

Abstract

Edema, defined as high signal intensity on T2-weighted images, is a useful breast MRI finding, which compensates for the moderate specificity of breast MRI. Although diffuse breast edema can be caused by benign and malignant etiologies, focal edema is commonly associated with malignancy except for previous procedures including biopsy and surgery. For more accurate comprehension of the appropriate usage of breast edema, focal breast edema should be divided into three different types: peritumoral edema, prepectoral edema, and subcutaneous edema. It is useful to review and clarify these types of focal breast edema based on pathological findings as this may help predict the likelihood of malignancy in breast MRI lesions.
Literature
1.
go back to reference Morris EA. Diagnostic breast MR imaging: current status and future directions. Radiol Clin North Am. 2007;45:863–80.PubMedCrossRef Morris EA. Diagnostic breast MR imaging: current status and future directions. Radiol Clin North Am. 2007;45:863–80.PubMedCrossRef
2.
go back to reference Kuhl CK. The current status of breast MR imaging. Part 1. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology. 2007;244:356–78.PubMedCrossRef Kuhl CK. The current status of breast MR imaging. Part 1. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology. 2007;244:356–78.PubMedCrossRef
4.
go back to reference Chatterji M, Mercado CL, Moy L. Optimizing 1.5-Tesla and 3-Tesla dynamic contrast-enhanced magnetic resonance imaging of the breasts. Magn Reson Imaging Clin N Am. 2007;18:207–24.CrossRef Chatterji M, Mercado CL, Moy L. Optimizing 1.5-Tesla and 3-Tesla dynamic contrast-enhanced magnetic resonance imaging of the breasts. Magn Reson Imaging Clin N Am. 2007;18:207–24.CrossRef
5.
go back to reference Uematsu T, Kasami M. High-spatial-resolution 3-T breast MRI of nonmasslike enhancement lesions: an analysis of their features as significant predictors of malignancy. AJR Am J Roentgenol. 2012;198:1223–30.PubMedCrossRef Uematsu T, Kasami M. High-spatial-resolution 3-T breast MRI of nonmasslike enhancement lesions: an analysis of their features as significant predictors of malignancy. AJR Am J Roentgenol. 2012;198:1223–30.PubMedCrossRef
6.
go back to reference Baltzer PA, Dietzel M, Kaiser WA. Nonmass lesions in magnetic resonance imaging of the breast: additional T2-weighted images improve diagnostic accuracy. J Comput Assist Tomogr. 2011;35:361–6.PubMedCrossRef Baltzer PA, Dietzel M, Kaiser WA. Nonmass lesions in magnetic resonance imaging of the breast: additional T2-weighted images improve diagnostic accuracy. J Comput Assist Tomogr. 2011;35:361–6.PubMedCrossRef
7.
go back to reference Baltzer PA, Yang F, Dietzel M, et al. Sensitivity and specificity of unilateral edema on T2w-TSE sequences in MR-mammography considering 974 histologically verified lesions. Breast J. 2010;16:233–9.PubMedCrossRef Baltzer PA, Yang F, Dietzel M, et al. Sensitivity and specificity of unilateral edema on T2w-TSE sequences in MR-mammography considering 974 histologically verified lesions. Breast J. 2010;16:233–9.PubMedCrossRef
8.
go back to reference Yuen S, Uematsu T, Kasami M, et al. Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis. J Magn Reson Imaging. 2007;25:502–10.PubMedCrossRef Yuen S, Uematsu T, Kasami M, et al. Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis. J Magn Reson Imaging. 2007;25:502–10.PubMedCrossRef
9.
go back to reference Uematsu T, Kasami M, Yuen S. Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology. 2009;250:638–47.PubMedCrossRef Uematsu T, Kasami M, Yuen S. Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology. 2009;250:638–47.PubMedCrossRef
10.
go back to reference Kawashima H, Kobayashi-Yoshida M, Matsui O, Zen Y, Suzuki M, Inokuchi M. Peripheral hyperintense pattern on T2-weighted magnetic resonance imaging (MRI) in breast carcinoma: correlation with early peripheral enhancement on dynamic MRI and histopathologic findings. J Magn Reson Imaging. 2010;32:1117–23.PubMedCrossRef Kawashima H, Kobayashi-Yoshida M, Matsui O, Zen Y, Suzuki M, Inokuchi M. Peripheral hyperintense pattern on T2-weighted magnetic resonance imaging (MRI) in breast carcinoma: correlation with early peripheral enhancement on dynamic MRI and histopathologic findings. J Magn Reson Imaging. 2010;32:1117–23.PubMedCrossRef
11.
go back to reference Malich A, Fischer DR, Wurdinger S, et al. Potential MRI interpretation model: differentiation of benign from malignant breast masses. AJR Am J Roentgenol. 2005;185:964–70.PubMedCrossRef Malich A, Fischer DR, Wurdinger S, et al. Potential MRI interpretation model: differentiation of benign from malignant breast masses. AJR Am J Roentgenol. 2005;185:964–70.PubMedCrossRef
12.
go back to reference Dietzel M, Baltzer PA, Vag T, et al. Application of breast MRI for prediction of lymph node metastases—systematic approach using 17 individual descriptors and a dedicated decision tree. Acta Radiol. 2010;51:885–94.PubMedCrossRef Dietzel M, Baltzer PA, Vag T, et al. Application of breast MRI for prediction of lymph node metastases—systematic approach using 17 individual descriptors and a dedicated decision tree. Acta Radiol. 2010;51:885–94.PubMedCrossRef
13.
go back to reference Uematsu T. MRI findings of inflammatory breast cancer, locally advanced breast cancer, and acute mastitis: T2-weighted images can increase the specificity of inflammatory breast cancer. Breast Cancer. 2012;19:289–94.PubMedCrossRef Uematsu T. MRI findings of inflammatory breast cancer, locally advanced breast cancer, and acute mastitis: T2-weighted images can increase the specificity of inflammatory breast cancer. Breast Cancer. 2012;19:289–94.PubMedCrossRef
14.
go back to reference Uematsu T, Kasami M, Watanabe J. Can T2-weighted 3-T breast MRI predict clinically occult inflammatory breast cancer before pathological examination? A single-center experience. Breast Cancer. 2014;21:115–21.PubMedCrossRef Uematsu T, Kasami M, Watanabe J. Can T2-weighted 3-T breast MRI predict clinically occult inflammatory breast cancer before pathological examination? A single-center experience. Breast Cancer. 2014;21:115–21.PubMedCrossRef
15.
go back to reference Uematsu T, Kasami M, Watanabe J. Is evaluation of the presence of prepectoral edema on T2-weighted with fat-suppression 3 T breast MRI a simple and readily available noninvasive technique for estimation of prognosis in patients with breast cancer? Breast Cancer. 2013. [Epub ahead of print]. Uematsu T, Kasami M, Watanabe J. Is evaluation of the presence of prepectoral edema on T2-weighted with fat-suppression 3 T breast MRI a simple and readily available noninvasive technique for estimation of prognosis in patients with breast cancer? Breast Cancer. 2013. [Epub ahead of print].
17.
go back to reference Dietzel M, Baltzer PA, Vag T, et al. Magnetic resonance mammography of invasive lobular versus ductal carcinoma: systematic comparison of 811 patients reveals high diagnostic accuracy irrespective of typing. J Comput Assist Tomogr. 2010;34:587–95.PubMedCrossRef Dietzel M, Baltzer PA, Vag T, et al. Magnetic resonance mammography of invasive lobular versus ductal carcinoma: systematic comparison of 811 patients reveals high diagnostic accuracy irrespective of typing. J Comput Assist Tomogr. 2010;34:587–95.PubMedCrossRef
18.
go back to reference Costantini M, Belli P, Distefano D, et al. Magnetic resonance imaging features in triple-negative breast cancer: comparison with luminal and HER2-overexpressing tumors. Clin Breast Cancer. 2012;12:331–9.PubMedCrossRef Costantini M, Belli P, Distefano D, et al. Magnetic resonance imaging features in triple-negative breast cancer: comparison with luminal and HER2-overexpressing tumors. Clin Breast Cancer. 2012;12:331–9.PubMedCrossRef
20.
go back to reference Blumgart EI, Uren RF, Nielsen PM, Nash MP, Reynolds HM. Predicting lymphatic drainage patterns and primary tumour location in patients with breast cancer. Breast Cancer Res Treat. 2011;130:699–705.PubMedCrossRef Blumgart EI, Uren RF, Nielsen PM, Nash MP, Reynolds HM. Predicting lymphatic drainage patterns and primary tumour location in patients with breast cancer. Breast Cancer Res Treat. 2011;130:699–705.PubMedCrossRef
22.
go back to reference Renz DM, Baltzer PA, Böttcher J, et al. Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study. Eur Radiol. 2008;18:2370–80.PubMedCrossRef Renz DM, Baltzer PA, Böttcher J, et al. Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study. Eur Radiol. 2008;18:2370–80.PubMedCrossRef
23.
go back to reference Yasumura K, Ogawa K, Ishikawa H, Takeshita T, Nakagawa Y, Osamura RY. Inflammatory carcinoma of the breast: characteristic findings of MR imaging. Breast Cancer. 1997;31:161–9.CrossRef Yasumura K, Ogawa K, Ishikawa H, Takeshita T, Nakagawa Y, Osamura RY. Inflammatory carcinoma of the breast: characteristic findings of MR imaging. Breast Cancer. 1997;31:161–9.CrossRef
24.
go back to reference Morakkabati N, Leutner CC, Schmiedel A, Schild HH, Kuhl CK. Breast MR imaging during or soon after radiation therapy. Radiology. 2003;229:893–901.PubMedCrossRef Morakkabati N, Leutner CC, Schmiedel A, Schild HH, Kuhl CK. Breast MR imaging during or soon after radiation therapy. Radiology. 2003;229:893–901.PubMedCrossRef
Metadata
Title
Focal breast edema associated with malignancy on T2-weighted images of breast MRI: peritumoral edema, prepectoral edema, and subcutaneous edema
Author
Takayoshi Uematsu
Publication date
01-01-2015
Publisher
Springer Japan
Published in
Breast Cancer / Issue 1/2015
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-014-0572-9

Other articles of this Issue 1/2015

Breast Cancer 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine